Patient groups push back against Gilead's pricey HIV prevention treatment

Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates.

from Reuters: Health News https://ift.tt/2KulNx7